Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medullary thyroid cancer.

Gary L Clayman1, Tarek S el-Baradie

  • 1Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 0441, Houston, TX 77030, USA. gclayman@mdanderson.org

Otolaryngologic Clinics of North America
|June 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Amnion/Chorion Membrane May Reduce Transient Recurrent Laryngeal Nerve Injury During Thyroid Surgery.

Cell transplantation·2022
Same author

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies.

Clinical cancer research : an official journal of the American Association for Cancer Research·2019
Same author

Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.

Head & neck·2017
Same author

Management of the central compartment in differentiated thyroid carcinoma.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017
Same author

Long-Term Outcomes of Lateral Neck Dissection in Patients with Recurrent or Persistent Well-Differentiated Thyroid Cancer.

Thyroid : official journal of the American Thyroid Association·2017
Same author

VISUAL VIGNETTE.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2017
Same journal

Obesity and Obstructive Sleep Apnea: Impact on Medical and Surgical Management.

Otolaryngologic clinics of North America·2026
Same journal

Little Tube; Big Problems: Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Current State of Button Battery Ingestion Injuries.

Otolaryngologic clinics of North America·2026
Same journal

Diagnostic Algorithm for Eustachian Tube Dysfunction and Indications for Balloon Dilation of the Eustachian Tube.

Otolaryngologic clinics of North America·2026
Same journal

Patulous Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Revisiting Eustachian Tube Anatomy and Physiology.

Otolaryngologic clinics of North America·2026
See all related articles

Medullary thyroid cancer (MTC) is a rare neoplasm originating from C cells, with hereditary forms linked to the RET proto-oncogene. Understanding MTC genetics aids early detection, screening, and treatment, with surgery offering the best cure potential.

Area of Science:

  • Oncology
  • Genetics
  • Endocrinology

Background:

  • Medullary thyroid cancer (MTC) is a rare malignancy originating from thyroid parafollicular C cells.
  • It presents sporadically or as part of hereditary multiple endocrine neoplasia syndromes (MEN2A, MEN2B).
  • The RET proto-oncogene is a key factor in hereditary MTC.

Purpose of the Study:

  • To summarize the current understanding of medullary thyroid cancer's genetic basis.
  • To highlight the impact of genetic knowledge on MTC management and prognosis.
  • To emphasize the need for interdisciplinary care in MTC.

Main Methods:

  • Review of current literature on medullary thyroid cancer genetics and management.
  • Analysis of the role of the RET proto-oncogene in hereditary MTC.

Related Experiment Videos

  • Discussion of surgical and prognostic factors in MTC.

    • Main Results:

    • Genetic knowledge, particularly regarding the RET proto-oncogene, is crucial for MTC screening, early detection, and prophylactic strategies.
    • Total thyroidectomy is the primary curative surgical intervention, requiring meticulous neck surveillance.
    • Disease stage and patient age are significant prognostic indicators for MTC.

    Conclusions:

    • Emerging molecular genetic insights into MTC are vital for future prognostic and therapeutic decisions.
    • Interdisciplinary management involving a team of specialists is essential for optimal patient care.
    • Continued research into MTC's genetic landscape will refine treatment approaches.